Background: Pain is the quintessential symptom for individuals suffering from sickle cell disease (SCD). Although the degree of suffering and the cost of treatment are staggering, SCD continues to be grossly understudied, including a lack of data for pain-related genes and prevalence of polymorphisms in this population. This lack of data adds to the inadequacy of pain therapy in this population. Pain genetics investigators have recently examined allele frequencies of single-nucleotide polymorphisms from candidate genes in people who have SCD. One of the genes identified was the arginine vasopressin receptor 1A gene (AVPR1A) and its associated singlenucleotide polymorphism (SNP) rs10877969. Progress in explaining pain-related polymorphisms associated with SCD can be facilitated by understanding the literature. Aim/Design: The purpose of this literature review was to describe mechanisms of the polymorphic gene AVPR1A and the phenotypic variations associated with its SNPs relative to health conditions and pain. Methods: Published studies were included if the research addressed AVPR1A and was a full article in a peer-reviewed journal, in the English language, a human or animal study, and published 2009 to present. Abstracts were included if they were in English and provided information not found in a full article. Results: The results of this review revealed that AVPR1A is associated with behavioral phenotypes, which include pair bonding, autism spectrum disorder, musical aptitude, infidelity, altruism, monogamy,
mating, substance abuse, and alcohol preference. In addition, there were associations with pain, stress pain by sex, and sickle cell pain. Conclusion: Summary of this literature could provide insights into future pain research of this SNP in people with SCD. Ó 2018 by the American Society for Pain Management Nursing
Arginine vasopressin is a seven-transmembrane-domain G-protein polypeptide that has been identified as being involved in many neurological functions, including aggression, bonding, sex behavior, autism, and schizophrenia (Kreek et al., 2011) . The single-nucleotide polymorphism (SNP) of the arginine vasopressin receptor 1A (AVPR1A) gene (rs10877969), is one of 115 polymorphisms of 49 genes that were previously identified as a candidate pain SNP (Jhun et al., 2015) . An SNP is a common type of base pair substitution, which may cause changes in protein expression that lead to differences in response to drugs, appearances, and response to environment. SNP rs10877969 is found in the promoter region of the AVPR1A gene on chromosome 12. Although this SNP has been identified as a pain-related SNP, association studies need to be performed. Some investigators have reported that rs10877969 plays a role in acute, neuropathic, and stress-related pain (Bagdas et al., 2013; Mogil et al., 2011) . In recent studies, investigators found that catechol-O-methyltransferase (COMT), which metabolizes catecholamines, and AVPR1A are involved in pain modulation (George et al., 2015; Jhun et al., 2014) . Some of the studies contained in this review include research that was completed using animal models. These models are important because some mechanisms are more readily accessible in animal models. Important functions of a DNA sequence tend to be highly conserved during evolution; the homolog (similar counterpart) will be recognizable in other species and in humans (ortholog) (Strachan et al., 2014) . For genes not yet extensively studied in humans, the research in animals can be informative to guide human research.
The state of the science relative to pain management is currently being expanded, in part because of animal models. For example, animal models were highly instrumental in the recent advances in the understanding of sickle cell disease (SCD) pain mechanisms. The emergence of SCD mouse models indicated their suitability as stable models for the study of pain in SCD, which include ''knockout mouse'' lines carrying exclusively human globulins after knocking out the mouse globulin gene in the Berkeley sickle cell mouse (Chang et al., 1998; Fabry et al., 1992; Gregory et al., 2013; Nagel & Fabry, 2001; Paszty et al., 1997; Ryan et al., 1997; Trudel et al., 1991; Wang & Wang, 2003) . The use of animal models has led to a better understanding of the types of pain commonly experienced by individuals who have SCD pain. From findings of these animal studies, mechanisms have been revealed and interventions have been explored for the neuropathic pain that this population experiences more than commonly thought (Molokie, Wang, & Wilkie, 2011; Molokie et al., 2014; Wilkie et al., 2010) .
We have entered the era of personalized medicine. As a result, nurses are poised to assess, treat, and educate patients about genetically influenced components of disease (Lashley, Kasper, & Schneidereith, 2016) . Genomic discoveries are rapidly advancing the science of health care (Hurle et al., 2013) . Using skilled assessments, nurses who are knowledgeable about genetics and genomics have the ability to help individuals understand and avert potential disorders and resulting morbidity and mortality (Calzone et al., 2010) .
The discovery that the SNP rs10877969 has a pain interaction associated with stress and sex led our team to ask, ''What additional findings about the function of this SNP could inform future research focused on the association of this SNP to variables important to pain of SCD?'' Specifically, a review of the AVPR1A literature can provide insights into future pain research of this gene and its associated SNP (rs10877969) in people with SCD and other pain conditions. Patients with SCD frequently report chronic, debilitating pain, yet the degree of that pain varies from patient to patient, even among individuals with the same sickle cell genotype (Adegbola, 2011) . Identifying genetic polymorphisms and their influence on pain phenotypes may result in a better understanding of some of the variations seen in SCD pain (Jhun et al., 2014) . Currently there is a lack of data for explaining pain-related polymorphisms associated with SCD, and this significantly impedes progress in this area of research. The purpose of this literature review was to examine the monoamine gene receptor AVPR1A and its SNP (rs10877969) to explore its mechanisms, associations with health conditions, and contributions to pain, including sickle cell pain. Genetic terms are defined in Table 1. METHOD rs10877969 initially yielded three citations. Because AVPR1A, the gene of interest, is a subgroup of the vasopressin receptor family (Birnbaumer, 2000) , the search was broadened using the terms ''Vasopressin,'' ''AV-PR1A,'' ''AVPR1A and polymorphism,'' ''AVPR1A and pain,'' ''AVPR1A and pain and polymorphism,'' and ''AVPR1A and sickle cell anemia or sickle cell disease'' as search terms. The search of the six different databases revealed 230 published articles.
As part of the selection process, a study was included if it was a full article, was published in a peer-reviewed journal, was written in English, and reported on human or animal studies. Abstracts were included if they were in English and provided information not found in a full article. The search years were limited to 2009 to present, because most SNP research related to pain was conducted starting in 2011. Publications were excluded if they were commentaries, editorials, unpublished dissertations, primarily review articles, educational material, or gray literature (scientific meetings, reports [preliminary, technical, government] , or documents) (Garrard, 2011; Lang, 2010) . Retrieved articles were screened based on title and abstract, and then a second review was performed. Two hundred thirty articles were screened by title and abstract, and 147 were excluded. Ancestral search and recommendations from experts in the fields were reviewed for further articles germane to the review topic and were not limited by years, but were limited by all other exclusion criteria. After review of studies from ancestral references and expert recommendations, 10 additional articles were acquired for eligibility determination. After further scrutiny, 50 articles were excluded for nonspecificity; those articles mainly focused on AVPR1B or AVPR2A. The remaining 43 full-text articles were reviewed, and an additional 19 were excluded because they did not provide new information about AVPR1A. Twenty-four articles remained (Fig. 1) for final synthesis.
RESULTS

Sample Characteristics
The 24 retained articles were grouped into the following categories based on content: mechanisms and health problems. The category mechanisms included articles exploring biochemical pathways, Artificially introduced DNA becomes incorporated into the germ line (Strachan et al., 2014) genomics, vasopressin, and oxytocin. The health problems were divided into three subgroups: (1) behavior/ social, which included autism, bonding, stress, aggression, sex differences, and addiction; (2) pain, which included nociceptive and neuropathic; and (3) sickle cell disease (Table 2) . The AVPR1A studies included humans (adults and pediatrics) and animals (rodents) and focused on mechanisms and health problems. The sample sizes for the human studies ranged from 33 to 1,517. Ten studies (42%) included humans, 9 (37%) included animals, 3 (13%) included both humans and animals, and 2 (8%) used cDNA from humans or animal. Eleven studies (38%) included mechanisms, and 18 (62%) included health problems: behavior/social (n ¼ 11), pain (n ¼ 6), and SCD (n ¼ 1). Some of the articles included more than one subgroup. Only one citation addressed AVPR1A and SCD.
In only four human studies, investigators reported ethnicity. One research group reported studying Amino acid identities among members of the G-protein-coupled superfamily and AVPR1A congregate inside the transmembrane domains. There is a 24%-30% sequence identity with the following receptors: human 5HT1a, rat substance P, rat D2 dopamine, and rat endothelin A.
Thibonnier et al., 1994
Describe the cloning, sequencing and functional expression of cDNA AVPR1A
Human Animal
Mechanisms. The structure and functional expression of human AVPR1A cDNA isolated from the liver Human AVPR1A receptor belongs to the prefamily of 7-transmembrane segment receptors with a significant sequence to the other members of the AVP-oxytocin family of receptors. Thibonnier et al., 1996 Describe genomic characteristics, tissue expression, chromosomal localization, and regional mapping of the human AVPR1A gene Human Mechanisms. Exploration of Northern blotting revealed presence of mRNA transcript (5.5kb), expressed in the liver, kidneys, heart, and skeletal muscle. Exploration with human genomic libraries revealed AVPR1a is included in its entirety and includes two coding exons (6.4 kb). When analyzing AVPR1A by PCR using hybrid somatic cells, localization to chromosome 12 was revealed, and in situ hybridization revealed that the gene was physically mapped to the 12q15-q15 region.
AVPR1A was physically mapped to chromosome 12, region12q14-q15.
Young et al., 1999
Behavior response differences in the prairie vole vs. the montane vole are related to AVPR1A receptor binding pattern differences between the species.
Animal (mice)
Behavior. Transgenic mice that have neuroanatomical patters of AVPR1A receptors in the brain similar to those of prairie voles. Gene expression for receptor AVPR1A located in the brain may be functionally associated with special typical behaviors in males.
Arginine vasopressin administered centrally increases affiliative behavior in the male monogamous prairie vole and not the promiscuous male montane vole.
Birnbaumer, 2000
Explore the biological effects of AVPR1A
cDNA isolation (tissue variability)
Mechanisms. Comparison of the structure of the three receptor subsites of AVP: structure, signaling, and testing.
Comparison of AVR to OTR.
Maintenance of water homeostasis is the most important physiological role of vasopressin Hawtin et al., 2002 Explore the V 1a receptor Nterminus and analyze individual residues that contribute to the agonistspecific interaction, evaluate the required sidechain properties, and suggest a mechanism of action.
Cell culture (HEK 293T cells) Arg46 has a critical function in receptor activation and high-affinity agonist binding. Arginyl is conserved in all neurohypophysial peptide hormone receptors, and may have a crucial role in the superfamily of GPCRs for interaction of agonist:receptor. May play a role in substance P binding. Lim et al., 2004 Demonstrate the role of AVR1A expression in social bonding.
Animals (voles)
Behavior. AVR1A is expressed in a higher concentration in monogamous, prairie voles than in promiscuous meadow voles. Partner preference on meadow voles was increased when exposed to AVR1A gene (via gene transfer) in the ventral forebrain.
Similar polymorphisms in the AVPR1A promoter region of humans have been linked to autism. Human AVR1A polymorphisms may contribute to human variability in social behavior.
Hammock and Young, 2005
To determine whether intraspecific variation in the microsatellite is sufficient to change gene expression
Behavior. There are significant genotype differences in the frequency of pup licking and grooming. In partner preference, long-and short-allele females spent equal amounts of time in total social contact. Long-allele males spent more time with their familiar partner than with the female stranger. Short-allele males did not display a partner preference.
Species-specific patterns of AVPR1A expression appear to be regulated by differences in a microsatellite in the 5 0 regulatory region of the gene encoding AVPR1A. Vasopressin systems contribute to male, not female, species-typical behaviors.
Koshimizu et al., 2006
Explore the role of the AVPR1A in cardiovascular homeostasis using gene targeting.
Animals (mice)
Mechanisms. No significant difference between the two groups in heart rate or cardiac function. No difference in heart weight. Mice exhibited altered pressor responses to AVP stimulation.
AVPR1a plays a role in normal resting arterial BP regulation mainly through its regulation of circulating blood volume and baroreflex sensitivity. Behavior. Significant association in AVPR1A with human personality traits. Alleles for polymorphic microsatellite repeats linked to autism are associated with differential amygdala activation and personality traits in humans.
Human amygdala function is strongly associated with genetic variation in AVPR1A.
Yang et al., 2010
Determine the association between AVPR1A and autism spectrum disorder (ASD). Caucasians only whereas another group reported studying African Americans (adults) and African origin (pediatrics), a third group of researchers reported studying individuals from West Africa, and a fourth group reported studying individuals from Korea.
Mechanism
Although the AVPR1A gene has three distinct receptors (AVP 1a , AVP 1b , and AVP 2 ) (Birnbaumer, 2000), for our purposes, this article focuses on the V 1a receptor. The protein name is vasopressin V1a receptor, and the gene family is arginine vasopressin and oxytocin receptors (Weizmann Institute of Science, 2015). The human AVPR1A gene is located on the long arm of chromosome 12 (12q14.2) (Babb et al., 2010; Bagdas et al., 2013; Birnbaumer, 2000; Thibonnier et al., 1994 Thibonnier et al., , 1996 Walum et al., 2008; Yang et al., 2010; Young, Nilsen, Waymire, MacGregor, & Insel, 1999) . The protein coded from this gene behaves as a receptor for arginine vasopressin and belongs to a family of G-protein-coupled receptors that include oxytocin. This family of G-coupled receptors mediates cell proliferation and contraction, platelet aggregation, glycogenolysis, and coagulation factor release (Weizmann Institute of Science, 2015). AVP 1a acts by binding to AVPR1A, where it stimulates Gq and activates phospholipase C-b, leading to the release of diacylglycerol and phosphatidylinositol (IP3). The latter induces the release of calcium from the endoplasmic reticulum (Yang et al., 2010) . Protein kinase C is activated by diacylglycerol and calcium. The gene is conserved in the human, rhesus monkey, chimpanzee, dog, cow, chicken, rat, frog, zebrafish, and Caenorhabditis elegans (Babb et al., 2010; Weizmann Institute of Science, 2015) . In some species, the seven-transmembrane peptide hormone consisting of nine amino acids (nonapeptide) has lysine in the eighth position, but in mammals it most commonly has arginine in the eighth position, which is why it is referred to as arginine vasopressin (Birnbaumer, 2000) . The human sequence is Cys-TyrPhe-Gly-Asn-Cys-Pro-Arg-Gly. The receptors for AVP 1a are located in the kidney, liver, peripheral vasculature, and brain (Hawtin et al., 2002) .
There are several aliases for the arginine vasopressin receptor 1A: vascular/hepatic-type arginine vasopressin receptor, AVPR V1a, AVPR1, V1aR, V1-vascular vasopressin receptor AVPR1A, SCCL vasopressin subtype 1a receptor, anti-diuretic hormone receptor 1A, anti-diuretic hormone receptor 1a, V1a vasopressin receptor, and vasopressin V1a receptor (Weizmann Institute of Science, 2015) . For the purposes of this article, we will use AVPR1A to discuss this gene and AVP 1a to discuss the receptor. Articles are listed chronologically because some of the articles include information relevant to more than one category.
History of AVPR1A Receptor Cloning
The cloning, sequencing, and functional expression of human cDNA for AVPR1A were described in 1994 by Thibonnier and his research team. They explored structure and functional expression of AVPR1A using cDNA isolated from livers of human participants (Thibonnier et al., 1994) . In 1996, the same research team used Northern blotting to reveal the presence of mRNA transcript (5.5 kb) expressed in the liver, kidneys, heart, and skeletal muscle (Thibonnier et al., 1996) . In the same year, further exploration with human genomic libraries indicated that AVPR1A was included in its entirety along with two coding exons (6.4 kb), and polymerase chain reaction (PCR) analysis of AVPR1A using hybrid somatic cells revealed localization to chromosome 12 (Thibonnier et al., 1996) . The gene was physically mapped to the 12q15-q15 region via in situ hybridization (Thibonnier et al., 1996) . Results from inositol phosphate production and calcium mobilization experiments confirmed that the receptor function was preserved and coupled to phospholipase C (Koshimizu et al., 2006) . Using cloned rat liver cDNA that encoded the AVPR1A gene, it was observed that the amino acid identifies among members of the G-protein-coupled superfamily, and AVPR1A congregates inside the transmembrane domains (Morel et al., 1992) . There is a 24%-30% sequence identity with the following receptors: human 5HT1a, rat substance P, rat D2 dopamine, and rat endothelin A (Morel et al., 1992) .
Binding to this receptor occurs in the AVP binding site at the N-terminal end of the AVPR (Hawtin et al., 2002) . Researchers examined the N-terminus of V 1a R and analyzed individual residues that contributed to the agonist-specific interaction (Hawtin et al., 2002) , Evaluating the mechanisms of action, researchers found that Arg46 has a critical function in receptor activation and high-affinity agonist binding (Hawtin et al., 2002) . In addition, arginyl, a residue of arginine, is conserved in all neurohypophysial peptide hormone receptors and may have a crucial role in the GPCR superfamily in agonist:receptor interaction (Hawtin et al., 2002) . Hasan et al. (2006) explored four novel SNPs in the promoter region of AVPR1A to evaluate if they could be used as a marker for divergent platelet aggregation response to AVP. There was a significant correlation (r ¼ 0.59, p < .001) between responses to AVP and those to adenosine diphosphate (ADP), but no differences in AVP-induced aggregation between subjects with and without variant alleles for the four SNPs. As a result, the four promoter region SNPs of the AVPR1A gene may not be useful as genetic markers for platelet aggregation heterogeneity (Hasan et al., 2007) .
In another study, investigators explored the role of AVPR1A in cardiovascular homeostasis using gene targeting (Koshimizu et al., 2006) . There was no significant difference between the two groups in heart rate, cardiac function, or heart weight. AVPR1A plays a role in normal resting arterial blood pressure regulation mainly through its regulation of circulating blood volume and baroreflex sensitivity, and mice exhibited altered vasopressor responses to AVP stimulation (Koshimizu et al., 2006) .
AVPR1A and Oxytocin
The human AVPR1A receptor belongs to the prefamily of seven-transmembrane segment receptors with a significant sequence identity to the other members of the AVP-oxytocin family of receptors (Koshimizu et al., 2006) . This receptor possesses high homology with other receptors found in the AVP and oxytocin family (Koshimizu et al., 2006) . The peptides AVP and oxytocin (OT) are closely related. Vasopressin and oxytocin are nonapeptides located in the pituitary, consisting of nine amino acids arranged in a cyclic structure and differing at only at the three and eight positions. Arginine and phenylanine in vasopressin are replaced by leucine and isoleucine in oxytocin (Baribeau & Anagnostou, 2015; Ebstein et al., 2009; Jern et al., 2012; Moons et al., 2014; Zietsch et al., 2015) . The structure of AVP is very similar to that of oxytocin, and oxytocin appears to interact with AVPR1A. Human AVP and oxytocin are located on the same chromosome, 12q14-q15, are separated by less than 15 bp in most species, and are both synthesized in the hypothalamus and secreted from the posterior pituitary gland into the bloodstream (Birnbaumer, 2000; GonzalezHernandez et al., 2014; Juif & Poisbeau, 2013) . Two primary functions of AVP are water and salt retention and vasoconstriction; other functions include cell proliferation, platelet aggregation, release of factor VIII, von Willebrand factor, social recognition, and circadian tau (Birnbaumer, 2000; Koshimizu & Tsujimoto, 2009; Koshimizu et al., 2006; Kreek et al., 2011; Moons et al., 2014) , whereas the major role of oxytocin is to regulate parturition, lactation, and bonding behavior (Schaschl et al., 2015) .
Behavioral Phenotypes
Arginine vasopressin plays a role in social behavior, jet lag, sexual motivation, and maternal bonding (close relationship to oxytocin) (Hammock & Young, 2005; Lim et al., 2004; Maher et al., 2011; MeyerLindenberg et al., 2009; Mogil et al., 2011; Walum et al., 2008; Yamaguchi et al., 2013; Young et al., 1999) . Researchers examined transgenic mice that 439 AVPR1A Gene Associations with Health and Pain had neuroanatomical patterns of AVP 1a receptors in the brain similar to those of prairie voles, a species used widely as an animal model in pair-bonding research, and reported that gene expression for receptor AVPR1A may be functionally associated with species-typical behaviors in males (Young et al., 1999) . Young et al. (1999) later went on to report that prairie voles and montane voles had speciesspecific behavior patterns associated with differences in a microsatellite in the 5 0 regulatory region that encodes AVPR1A (Hammock & Young, 2005) , where selective blocking of AVPR1A in the ventral pallidum, a reward circuit pathway, decreases pair bonding in prairie voles; therefore, AVPR1A is critical for pair ponding (Hammock & Young, 2005) . While studying double knockout mice that lacked receptors for both AVP 1a and AVP 1b , it was found that these mice were resistant to jet lag, suggesting that vasopressin signaling may also be a target for managing circadian misalignment (Yamaguchi et al., 2013) .
Studies, in both humans and animals, on the roles of oxytocin and arginine vasopressin (AVPR1A) have indicated that they play a role in social processes in mammals with respect to social deficits and neurodevelopmental disorders, including autism spectrum disorder and ejaculatory function (Baribeau & Anagnostou, 2015; Jern et al., 2012; Lim et al., 2004) .
The 5 0 flanking region of AVPR1A contains three polymorphic microsatellite repeats ([GT] 25 , RS1, and RS3) where activation stimulates phospholipase C. Differing lengths of these repeats have been described in various studies and are associated with behavioral traits, suggesting that they are relevant to brain function related to emotional arousal and social behavior. Subjects with a shorter RS3 (repeat sequence microsatellite) have been reported to exhibit less altruistic behavior. Several AVPR1A promoter SNPs were reported to be associated with autism spectrum disorders. Longer AVPR1A RS3 alleles were reported to be associated with elevated levels of prepulse inhibition (the weaker prestimulus inhibits reaction to a subsequent stronger stimulus), particularly in healthy males (Kreek et al., 2011) . This AVPR1A association with the well-known neurobiological phenomenon of prepulse inhibition suggests that a weak startling sound or nonnoxious tactile stimuli in those with longer AVPR1A RS3 alleles could blunt future reactions to strong startling stimuli, and this decreased startle effect may differ by sex (Kreek et al., 2011) . Yang et al. (2010) investigated the association of Korean autism spectrum disorder (ASD) families with three AVPR1A SNPs. They reported a possible association between the SNPs and the phenotype of ASD. The findings were statistically significant for association between autism and SNPs in the promoter region of chromosome 12 (Yang et al., 2010) . Pain Vasopressin has been described as playing a crucial role in the modulation of pain, and several studies have reported that AVP can regulate the pain process in the brain through the mediation of central cholinergic and opioidergic systems (Bagdas et al., 2013; Mogil et al., 2011) . In a recent study, a three-way interaction between genetics (AVPR1A, re10877969), sex, and acute stress was observed in both mice and humans. Male volunteers reported stress at the time of testing (capsaicin pain) that differed based on genotype; no effects of stress on genotype were observed in women (Mogil et al., 2011) . Allele frequencies of rs10877969 differed in white and Asian versus African American volunteers, and the lower pain rating of male volunteers was not observed in African Americans (Mogil et al., 2011) . The involvement of AVPR1A in capsaicin pain indicates that vasopressin may have analgesic properties against this pain modality (Mogil et al., 2011) . The mouse AVPR1A gene, encoding for AVP 1a , translates to humans in its role in pain and genotype interactions with sex and acute stress (Mogil et al., 2011) . Further examination of the model revealed an endogenous pain relief pathway induced by stress and mediated by AVPR1A, which was replicated cross-species (between mouse and human) in a three-way interaction among genotype, stress level, and sex (Wiltshire et al., 2011) .
Another genetic association model was used to observe physical impairment and acute pain. Parr et al. (2012) examined AVPR1A and SNP rs10877969 along with SNPs of other genes and described them as having an impact on physical impairment and range of motion. Flexion and range of motion deficits were associated with AVPR1A and COMT, whereas internal rotation and abduction deficits were associated with AVPR1A. Physical impairment in range of motion and strength had a stronger association with variation in inflammatory and pain-modulating genes in comparison to psychological factors in which all predictors had p values < .05 (Parr et al., 2012) . It was later reported that, after muscle injury, neuronal excitability and vasopressin-mediated endogenous analgesia may affect the pain-related influence of emotional or cognitive states (George et al., 2014) . The interaction between pain catastrophizing and depression revealed the phenotype for shoulder pain duration. SNPs from the gene AVPR1A were determined to be possible predictors of shoulder pain duration. Future investigations may explore similar interactions to determine the clinical applicability to the prediction of treatment outcomes.
Studies indicate that both OT and AVR play a role in the inhibition of nociception, but the identity of the main receptor remains obscure. Peng et al. (2015) found that the anti-nociceptive effect of formalin induced spontaneous nociception. In this study, they reported that spinal AVP reduced pain responses when mice were injected with 5% formalin, which induced spontaneous nociceptive behavior (licking and lifting of the injection site). Spinal dose reduced formalin-induced spontaneous nociception in wildtype mice and had no effect on mice that had been genetically modified (AVP 1a receptor knockout) (Peng et al., 2015) .
Oxytocin has been reported to medicate pain by blocking the activity of blocking A delta and C fibers and by activating various pathways in the neuronal system. Studies that explore analgesia at the periphery have indicated oxytocin receptor (OTR) involvement, whereas others have indicated AVPR1A involvement (Ebstein et al., 2012; Gonzalez-Hernandez et al., 2014) .
Using cytidine-5 0 -diphosphate-choline (CDPcholine, citicoline) in the rat model, Bagdas et al. (2013) examined analgesic responses via CDPcholine. CDP-choline enhances central and peripheral vasopressin levels in acute, inflammatory, and chronic injury-induced neuropathic pain models in rats without any motor impairment (Bagdas et al., 2013) . Centrally administered CDP-choline elicited an analgesic effect through central cholinergic and opioidergic systems, providing evidence for the utility of centrally acting cholinergic and vasopressinergic agonists in the management of acute and neuropathic pain (Bagdas et al., 2013; Ballas et al., 2012) . Jhun et al. (2015) recently reported on patients with SCD from two institutions who participated in a pain study exploring pain phenotypes. The population consisted of African American adults and pediatric patients of African origin. Jhun et al. (2015) explored 115 painrelated SNPs in 49 candidate genes and compared them with the current literature. The genes and related SNPs are thought to be parts of the monoamine neurotransmitter system and have been previously implicated in pain. The AVPR1A gene and a related SNP (rs10877969) were identified in this study as prospective candidate for studies on pain genetics (Jhun et al., 2015) .
Sickle Cell Disease
DISCUSSION
The purpose of this literature review on the polymorphisms of AVPR1A was to examine its mechanisms and associated health conditions, including SCD. This review indicates that studies on pain-related SNPs are limited in number, and studies on pain-related SNPs in the sickle cell population are even more limited. In a recent study, rs10877969 was found to have a possible role in differences in the perception of pain.
In the Mechanism section, we explored current research on the function of this receptor and current mechanisms for cloning and genotyping. AVPR1A was found to be highly linked to the oxytocin receptor (Baribeau & Anagnostou, 2015; Birnbaumer, 2000; Gonzalez-Hernandez et al., 2014; Jern et al., 2012; Juif & Poisbeau, 2013; Moons et al., 2014) , which explains some of the overlap in functions.
AVPR1A binding has been reported to be highly linked to behaviors and behavioral health conditions. The most prevalent health condition associated with behavior was ASD (Baribeau & Anagnostou, 2015; Meyer-Lindenberg et al., 2009; Yang et al., 2010) . Associated with features seen in ASD, AVPR1A was observed to be linked to associated behaviors such as bonding, stress, and addiction (hyper fixation) (Baribeau & Anagnostou, 2015; Hammock & Young, 2005; Lutz et al., 2015; Maher et al., 2011; Moons et al., 2014; Ukkola-Vuoti et al., 2011; Walum et al., 2008; Yang et al., 2010) . A recent study exploring genetic factors and physical impairment reported that AVPR1A has a role in pain modulation for acute shoulder pain (George et al., 2014) . More recently, a three-way interaction was observed between sex, environment, and stress. This interaction occurred in both the animal and human models (Mogil et al., 2011; Wiltshire et al., 2011) .
Although the findings regarding AVPR1A and SCD are limited to only one publication, the findings from another study suggested a link to SCD pain for newly explored pain SNPs (Jhun et al., 2015) . Jhun et al. (2014) found that DRD3 Ser9Gly and COMT Val158Met may contribute to pain heterogeneity in SCD. They also found that patients were likely to have higher acute care utilization for acute pain if they had the COMT 158 Met allele or Met/Met genotype. Similar clinical SCD investigations are warranted for AVPR1A.
This review explored the AVPR1A SNP and associated health problems (social/behavioral, pain, and sickle cell disease). Limitations of this review include the recognition that SCD is understudied and additional studies need to be done to explore polymorphisms related to pain that could result in more desirable patient outcomes with respect to pain. Other studies, such as those reported in languages other than English, may provide additional insight into the function of AVPR1A.
In summary, future pain-related SCD research should include exploration of rs10877969 using 441 AVPR1A Gene Associations with Health and Pain sufficiently sized samples and further exploration of differences between genotypes in African Americans compared with individuals of African origin. In addition, studies are warranted to explore AVPR1A for associations with acute or chronic pain of SCD and to determine if stress or sex is associated with AVPR1A and clinical SCD pain. Information gained from this review will serve to increase understanding of the contributions that genetics and genomics play in health science to aid in health promotion and disease prevention, inform policy-making groups, and guide future research that generates new knowledge for clinical practice and is focused on improving safe and effective pain management (Calzone et al., 2010) .
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